Jean-marc M. Gornet

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 89 publications

IL-10-neutralising autoantibodies in paediatric-onset inflammatory bowel disease.

IL-10-neutralising autoantibodies in paediatric-onset inflammatory bowel disease.

Journal: Gut

Published: March 26, 2026

Liver and peritoneal metastases of unknown primary site: French Intergroup Clinical Practice guidelines for diagnosis, treatment, and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, SFP, SFR, ACHBT, SFRO, SNFCP, AFEF, RENAPE, NET-CAPI).

Liver and peritoneal metastases of unknown primary site: French Intergroup Clinical Practice guidelines for diagnosis, treatment, and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, SFP, SFR, ACHBT, SFRO, SNFCP, AFEF, RENAPE, NET-CAPI).

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 13, 2026

Development and External Validation of a Predictive Model for Postoperative Recurrence of Crohn's Disease in the Biologic Era.

Development and External Validation of a Predictive Model for Postoperative Recurrence of Crohn's Disease in the Biologic Era.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: January 24, 2026

Diagnosis and management of patients with Crohn's disease. Position paper from the GETAID.

Diagnosis and management of patients with Crohn's disease. Position paper from the GETAID.

Journal: Clinics and research in hepatology and gastroenterology

Published: October 27, 2025

Expert endoscopic surveillance in CDH1 pathogenic variant carriers seems safe, even after positive (pT1a) biopsies.

Expert endoscopic surveillance in CDH1 pathogenic variant carriers seems safe, even after positive (pT1a) biopsies.

Journal: Journal of medical genetics

Published: September 15, 2025

Blood proteomic signatures associated with disease activity in inflammatory bowel diseases.

Blood proteomic signatures associated with disease activity in inflammatory bowel diseases.

Journal: Journal of Crohn's & colitis

Published: September 08, 2025

Impact of postoperative chemotherapy in patients resected for esophagogastric adenocarcinoma with major pathological response after preoperative chemotherapy: a study from the FREGAT database.

Impact of postoperative chemotherapy in patients resected for esophagogastric adenocarcinoma with major pathological response after preoperative chemotherapy: a study from the FREGAT database.

Journal: Therapeutic advances in medical oncology

Published: August 30, 2025

Impact of Histological Remission for Predicting Clinical Relapse in Crohn's Disease: A Post Hoc Analysis of the Prospective STORI Cohort.

Impact of Histological Remission for Predicting Clinical Relapse in Crohn's Disease: A Post Hoc Analysis of the Prospective STORI Cohort.

Journal: Journal of Crohn's & colitis

Published: November 02, 2024

PErsistence and Safety of Subcutaneous Infliximab 1 Year After Switch From Intravenous Route in IBD Patients in REMission.

PErsistence and Safety of Subcutaneous Infliximab 1 Year After Switch From Intravenous Route in IBD Patients in REMission.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: September 26, 2024

Risk of anti-TNF therapy on pregnancy, breastfeeding, live vaccines and related information in patients with inflammatory bowel disease: Real-world data from a nationwide study.

Risk of anti-TNF therapy on pregnancy, breastfeeding, live vaccines and related information in patients with inflammatory bowel disease: Real-world data from a nationwide study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: March 05, 2024

Infliximab desensitization in patients with inflammatory bowel diseases: a safe therapeutic alternative.

Infliximab desensitization in patients with inflammatory bowel diseases: a safe therapeutic alternative.

Journal: Scandinavian journal of gastroenterology

Published: February 14, 2024

Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases.

Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases.

Journal: British journal of cancer

Published: September 20, 2023

Showing 1-12 of 89

Last Updated: 09/26/2026